Showing 1,491 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

PrEP policies & guidelines

Is Off-Label HIV Prevention Better Than None?

Editor's pick
MedPage Today (requires free registration)
31 May 2019
PrEP policies & guidelines

The truth is you can afford the medication that prevents HIV. Here’s how.

Editor's pick
LGBTQ Nation
24 May 2019
PrEP policies & guidelines

A Review of the Congressional Hearing on HIV Drug Pricing

Editor's pick
POZ
23 May 2019
Finance & funding

Analysis reveals extent of drug industry funding of UK patient organisations

Editor's pick
The BMJ press release
23 May 2019
Pharmaceutical industry

Medicare decides against tighter management of HIV drugs

Editor's pick
BioPharma Dive
21 May 2019
PrEP policies & guidelines

Republicans defend drug company in spotlight over HIV medication prices

Editor's pick
The Hill
17 May 2019
Pharmaceutical industry

Trump Administration Caves To Pharma On Medicare Part D 'Protected Classes' Reform

Editor's pick
Forbes
17 May 2019
Pharmaceutical industry

A Leading HIV Drug Is Way Overpriced in the U.S.

Editor's pick
Bloomberg
17 May 2019
Pharmaceutical industry

Alexandria Ocasio-Cortez Tells Gilead CEO That ‘People Are Dying’ Because His Company Charges Nearly $2,000 For Drug That Sells For $8 In Australia

Editor's pick
Newsweek
17 May 2019
Pharmaceutical industry

Gilead Sciences Statement On Inaccurate Reporting On Truvada®

Editor's pick
Gilead press release
16 May 2019
Pharmaceutical industry

Gilead tries—and fails—to dodge lawsuit claiming it delayed safer HIV meds

Editor's pick
Fierce Pharma
15 May 2019
Pharmaceutical industry

Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says

Editor's pick
STAT
15 May 2019
PrEP policies & guidelines

Statement on Gilead’s Announcement of PrEP Donation

Editor's pick
AVAC
14 May 2019
PrEP programmes & uptake

A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.

Editor's pick
The New York Times (editorial)
14 May 2019
Pharmaceutical industry

Generics price-fixing lawsuit focuses on Teva's role as catalyst

Editor's pick
Bio Pharma Dive
14 May 2019
PrEP policies & guidelines

Five Reasons the Gilead Giveaway is a Steaming Pile of Truvada

Editor's pick
My Fabulous Disease
12 May 2019
Pharmaceutical industry

Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say

Editor's pick
New York Times
12 May 2019
PrEP policies & guidelines

Generic PrEP to Arrive in September 2020, but Will Big Savings Follow?

Editor's pick
Poz
10 May 2019
Pharmaceutical industry

Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

Editor's pick
The New York Times
10 May 2019
Pharmaceutical industry

Group Of Developed Countries Seek To Delay Italian Proposal On Drug Price Transparency

Editor's pick
Health Policy Watch
7 May 2019
Pharmaceutical industry

Gilead Sciences Returns to Growth in the First Quarter

Editor's pick
Motley Fool
3 May 2019
PrEP policies & guidelines

Gilead: Stop Blocking PrEP

Editor's pick
Act Up Dublin
1 May 2019
Elimination of hepatitis C

NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

Editor's pick
pharmaphorum
30 April 2019
Elimination of hepatitis C

NHS England strikes world leading deal to help eliminate hepatitis C

Editor's pick
NHS England
30 April 2019